Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Increased intake of dietary fiber lowers risk of hypertension and type 2 diabetes

Dietary fiber has been found to reduce the risk of high blood pressure and type 2 diabetes in a study presented at the American College of Cardiology Middle East Conference 2019.

3 Oct 2019

Innovative compound kills cancer cells, minimizes damage to normal tissues

Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient's blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as "collateral damage", leading to undesired side effects.

3 Oct 2019

Certain fungi increase pancreatic cancer risk, study finds

Certain fungi move from the gut to the pancreas, expand their population more than a thousand-fold, and encourage pancreatic cancer growth, a new study finds.

2 Oct 2019

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.

30 Sep 2019

New trial shows improved survival for patients with advanced colorectal BRAF-mutant cancer

A clinical trial has shown that using a combination of three drugs that target a BRAF gene mutation in patients with mCRC effectively boosts overall survival.

30 Sep 2019

Study: Three-drug combination improves overall survival in patients with mCRC

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

30 Sep 2019

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

25 Sep 2019

Global survey highlights unmet need of women living with cancer

Merck, a leading science and technology company, today released the Supporting Women With Cancer report, presenting findings from a global survey of 4,585 women across 23 countries.

25 Sep 2019

Web-based tool predicts risks of conditions in middle-aged women

A web-based calculator that helps middle-aged women predict their risks of conditions that become more likely with age has been developed by public health, medical and computer science experts from throughout the U.S. and Saudi Arabia.

25 Sep 2019

Onion and garlic may reduce risk of breast cancer

Onion and garlic are staple spices for many cuisines across the globe. There are numerous recipes requiring these two elements, and they may now be key ingredients in cutting the risk of breast cancer.

24 Sep 2019

Discrete choice experiments can predict real-world healthcare choices, research shows

Value in Health, the official journal of ISPOR- the professional society for health economics and outcomes research, announced today the publication of research demonstrating that discrete choice experiments are able to predict real-world healthcare choices.

23 Sep 2019

Research shows how bowel cancer screening helps reduce deaths

New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to reduce the number of bowel cancer deaths by up to 45 per cent.

20 Sep 2019

Study finds increase in health gap between First Nation people and other Manitobans

The health gap between First Nation people and all other Manitobans is growing.

20 Sep 2019

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.

19 Sep 2019

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.

18 Sep 2019

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

Patients with metastatic colorectal cancer harboring a subset of non-V600 mutations in the BRAF gene, known as class 3 BRAF mutations, were more likely to respond to anti-EGFR treatment.

12 Sep 2019

ECLS trial demonstrates potential of blood test for early lung cancer detection

Oncimmune Holdings plc, a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.

12 Sep 2019

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Increased intake of dietary fiber lowers risk of hypertension and type 2 diabetes

Innovative compound kills cancer cells, minimizes damage to normal tissues

Certain fungi increase pancreatic cancer risk, study finds

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

New trial shows improved survival for patients with advanced colorectal BRAF-mutant cancer

Study: Three-drug combination improves overall survival in patients with mCRC

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

Global survey highlights unmet need of women living with cancer

Web-based tool predicts risks of conditions in middle-aged women

Onion and garlic may reduce risk of breast cancer

Discrete choice experiments can predict real-world healthcare choices, research shows

Research shows how bowel cancer screening helps reduce deaths

Study finds increase in health gap between First Nation people and other Manitobans

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

Metastatic colorectal cancer patients with certain BRAF mutations may respond to anti-EGFR therapy

ECLS trial demonstrates potential of blood test for early lung cancer detection

Cancer disease incidence and severity influenced by gene mutation, tissue location

New liquid biopsy test may be more predictive of patient's immunotherapy response

Gut microbiome could be used to predict individual's risk of bowel cancer

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in